|
|

Title: Inhalation therapy decongestant with foraminous
carrier
United States Patent: 6,090,403
Inventors: Block; Leslie L. (Chaska, MN); Goon; David J. W.
(Bloomington, MN); Rolf; David (Eden Prairie, MN)
Assignee: LecTec Corporation (Minnetonka, MN)
Appl. No.: 135104
Filed: August 17, 1998
Abstract
A vaporizable decongestant is supported and stabilized on a flexible
foraminous carrier composed typically of open-cell plastic foam, cloth or
other fibrous material such as nonwoven fabric. The term "foraminous"
herein is intended to refer to a substance or medium containing minute
openings or perforated by many minute apertures. The decongestant is
placed on the surfaces within the interstices and minute apertures or on
fibers from which the foraminous carrier is formed. Vaporization of the
inhalable decongestant is facilitated by providing the potential for
greatly increasing its exposed surface area. Distributing the decongestant
composition over the large, expanded surface within the foraminous carrier
is beneficial in enhancing both the volatilization and evaporation of the
decongestant agent. It also prolongs the useful life of the product. Once
vaporized, the aromatic decongestant is available for natural inhalation
through the nose or mouth to help relieve one or more of the symptoms of
cough, colds, nasal or chest congestion and related symptoms. The
foraminous carrier is preferably provided in the form of a patch or sheet
that is bonded to the skin to serve as a supporting base for the active
decongestant agent. The patch defining the carrier is typically adhesively
bonded to the upper part of the body, e.g. on the face, neck or chest, in
a location where the decongestant is liberated into the air and can be
inhaled through the mouth or nose.
SUMMARY OF THE INVENTION
The present invention provides a decongestant, preferably
an aromatic, vaporizable decongestant supported on a foraminous carrier
composed typically of an open-cell plastic foam, perforated plastic film,
cloth or other fibrous material such as nonwoven fabric. The term "foraminous"
herein is intended to refer to a substance or medium containing minute
openings or perforated by many minute apertures. To form such a product in
accordance with the present invention, an inhalable decongestant is placed
on surfaces within the interstices and minute apertures or on fibers of
which the foraminous carrier is composed. In this way vaporization of the
inhalable decongestant is facilitated by providing the potential for
greatly increasing its exposed surface area. Thus, distributing the
decongestant composition over the large, expanded surface within the
foraminous carrier is beneficial in enhancing both the volatilization and
evaporation of the decongestant agent. It also helps to prolong the useful
life of the product. Once vaporized, the aromatic decongestant is
available for natural inhalation through the nose or mouth to help relieve
one or more of the symptoms of cough, colds, nasal or chest congestion and
related symptoms. The foraminous carrier is preferably provided in the
form of a patch or sheet that is bonded to the skin and acts as a
supporting base for the active decongestant agent.
The patch defining the carrier is placed on the upper part of the body,
typically on the face, neck or chest, in a location where the decongestant
is liberated into the air and can be inhaled through the mouth or nose.
The patch which serves as a carrier for the decongestant is bonded to the
skin either through the provision of an adhesive on the lower surface of
the patch or by means of a separate piece of pressure-sensitive adhesive
tape or adhesive coating, either surrounding the carrier or applied along
the edges of the lower surface of the carrier.
The decongestant can be applied to the foraminous carrier in various ways.
For example, by spraying, roll-coating, dipping, knife-coating, or
calendering. If desired, the decongestant agent can extend substantially
through the entire thickness of the carrier sheet. It is preferred that
the entire patch be non-occlusive, i.e. capable of allowing moisture from
the skin to diffuse outwardly and escape through the upper surface of the
patch. However, if desired, the foraminous carrier sheet can be provided
as an upper layer of the patch which is bonded to a non-porous sheet
material such as a sheet of plastic film having a separate layer of
pressure-sensitive adhesive on its lower surface for bonding the patch to
the skin. In this case, the patch as a whole is occlusive and as such will
not allow moisture to escape from the skin.
A variety of well known therapeutic agents that have a decongestant or
analgesic action can be employed. Examples include oil of wintergreen,
menthol, thymol, camphor, oil of peppermint, eucalyptus oil, phenylephrine
hydrochloride, pheniramine maleate, benzalkonium chloride, methyl
salicylate, pseudoephedrine hydrochloride, oxymetazoline hydrochloride,
xylometazoline hydrochloride, methazoline hydrochloride, epinephrine,
spirits of turpentine, ephedra (ma huang), coltsfoot (Tussilago farfara
L.), ginger (Zingiber officinale), naphazoline hydrochloride, and other
decongestants known in the art. We have found that the turpentine, because
of its volatility, appears to help co-evaporate other active decongestant
agents. To prepare the patch, the decongestant, i.e. the therapeutic
agent, is preferably dispersed in a vehicle to form an ointment that can
either be hydrophilic or hydrophobic in nature. A typical hydrophilic
vehicle preferably includes a thickener comprising a water-dispersible or
water-swellable natural or synthetic polymer. The thickener raises the
viscosity to a level that resists spreading and can, if desired, cause the
ointment to set-up as an elastic solid. A hydrophilic ointment also
contains water and a humectant such as a polyhydric alcohol. Typical
hydrophobic vehicles comprise mineral oil or petroleum jelly, or a
combination thereof, in which decongestant agents are dispersed or
dissolved. Another hydrophobic vehicle comprises a pressure-sensitive
adhesive matrix such as a dispersion of natural or synthetic rubber, an
oleaginous plasticizer such as mineral oil, and a tackifying resin such as
a terpene resin. Other adhesives can be used, such as vinyl emulsion
adhesives, acrylic polymeric adhesives, vinyl acetate copolymers or
silicone adhesives. Other medical adhesives which can be used will be
apparent to those skilled in the art.
When the decongestant agents are mixed with the vehicle, an ointment is
produced. The ointment is then stabilized by applying it to the greatly
expanded surface area within the minute apertures and interstices between
the fibrils, perforations and/or pores of the foraminous carrier. This,
together with a thickening agent that can, if desired, be contained in the
ointment, gives the ointment sufficient body, support and stability to
hold it in place and prevent it from becoming smeared onto fingers,
clothing, bed linens or onto other parts of the body where one or more of
the decongestant agents could cause irritation, such as nasal mucosa or
the eyes. In addition, the foraminous carrier supporting the decongestant
enables all of the decongestant material to be easily and quickly removed
when no longer needed with little or no residue left on the skin. In
addition, by distributing the ointment over the extended surface of the
foraminous carrier, more of the decongestant can be exposed to the air.
The much greater exposed surface area facilitates evaporation of the
decongestant, thus allowing more of the active agents it to be inhaled so
as to improve the reduction of nasal or chest congestion and related cold
and sinus symptoms.
Claim 1 of 41 Claims
1. A skin patch for the relief of the symptoms of cough,
colds, nasal congestion or chest congestion, comprising,
symptomatic cold reliever supported upon a non-occlusive flexible
foraminous carrier and means operatively associated with the carrier for
securing the carrier to the skin surface to enable said symptomatic cold
reliever to be available for natural inhalation during respiration through
the mouth or nose;
wherein the skin patch is free of a 5-substituted furan methyl ketone.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|